A microneedle patch containing measles vaccine is immunogenic in non-human primates

Vaccine
Chris EdensMark R Prausnitz

Abstract

Very high vaccination coverage is required to eliminate measles, but achieving high coverage can be constrained by the logistical challenges associated with subcutaneous injection. To simplify the logistics of vaccine delivery, a patch containing micron-scale polymeric needles was formulated to encapsulate the standard dose of measles vaccine (1000 TCID₅₀) and the immunogenicity of the microneedle patch was compared with subcutaneous injection in rhesus macaques. The microneedle patch was administered without reconstitution with diluent, dissolved in skin within 10 min, and caused only mild, transient skin erythema. Both groups of rhesus macaques generated neutralizing antibody responses to measles that were consistent with protection and the neutralizing antibody titers were equivalent. In addition, the microneedle patches maintained an acceptable level of potency after storage at elevated temperature suggesting improved thermostability compared to standard lyophilized vaccine. In conclusion, a measles microneedle patch vaccine was immunogenic in non-human primates, and this approach offers a promising delivery method that could help increase vaccination coverage.

References

Nov 1, 1990·The Journal of Infectious Diseases·R T ChenW A Orenstein
May 14, 1966·Lancet·C CooperA J Beale
Nov 5, 1997·Biologicals : Journal of the International Association of Biological Standardization·F T CuttsJ V Bennett
Apr 24, 2004·The Journal of Infectious Diseases·Mark S DineStephen C Redd
May 4, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jung-Hwan ParkMark R Prausnitz
May 24, 2007·IEEE Transactions on Bio-medical Engineering·Jung-Hwan ParkMark G Allen
Dec 8, 2007·Vaccine·Bernard J CohenUNKNOWN WHO working group on measles plaque reduction neutralization test
Feb 12, 2008·Biomaterials·Jeong W LeeMark R Prausnitz
Sep 1, 2009·Vaccine·Stephane GuichardMohd Mahbubur Rahman
Oct 21, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yeu-Chun KimMark R Prausnitz
Apr 16, 2010·Journal of the Royal Society, Interface·Michiel van BovenSusan Hahné
Jul 20, 2010·Nature Medicine·Sean P SullivanMark R Prausnitz
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Wen-Hsuan LinScott Winston
Jun 17, 2011·The Journal of Infectious Diseases·Peter M StrebelSamuel L Katz
Jun 17, 2011·The Journal of Infectious Diseases·William J Moss, Peter Strebel
Jun 17, 2011·The Journal of Infectious Diseases·Ann LevinAlya Dabbagh
Oct 4, 2011·Virus Research·William J Bellini, Paul A Rota
Apr 21, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kazuhiko MatsuoShinsaku Nakagawa
May 3, 2012·Vaccine·James L GoodsonPeter M Strebel
May 12, 2012·Advanced Drug Delivery Reviews·Yeu-Chun KimMark R Prausnitz
Oct 10, 2012·Vaccine·Chris EdensMark R Prausnitz
May 15, 2013·Expert Opinion on Drug Delivery·Saradha ChandrasekharVasant V Ranade
Jan 16, 2014·Clinical and Experimental Vaccine Research·Hyemee SuhYeu-Chun Kim

❮ Previous
Next ❯

Citations

Nov 13, 2015·Expert Opinion on Drug Delivery·N Sanoj RejinoldYeu-Chun Kim
Sep 1, 2015·Vaccine·Marcel B M Teunissen, Darin Zehrung
Aug 5, 2015·Journal of Clinical Pharmacology·Philip Zachariah, Melissa S Stockwell
Nov 26, 2015·Trends in Molecular Medicine·Iana H HaralambievaGregory A Poland
Nov 26, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jaya Arya, Mark R Prausnitz
Mar 20, 2016·Current Opinion in Biotechnology·Andrew B HillCharles H Jones
Nov 28, 2015·Infectious Disease Clinics of North America·James L Goodson, Jane F Seward
Jun 7, 2016·Acta Biomaterialia·Dan Dan ZhuXin Dong Guo
Jun 22, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·E Stein EsserIoanna Skountzou
Jun 11, 2016·Journal of Drug Targeting·Hye-Rin JeongJung-Hwan Park
Feb 26, 2016·Expert Review of Vaccines·Heleen KraanJean-Pierre Amorij
Jul 15, 2016·Nature Reviews. Disease Primers·Paul A RotaJames L Goodson
Aug 31, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shinying LauRan Liu
Oct 19, 2016·Human Vaccines & Immunotherapeutics·Sarah MarshallAnne C Moore
Jun 3, 2016·Scientific Reports·Michael Lawrence CrichtonMark Anthony Fernance Kendall
May 23, 2017·Therapeutic Delivery·Chong In ShinYeu-Chun Kim
Apr 5, 2017·Annual Review of Chemical and Biomolecular Engineering·Mark R Prausnitz
Apr 7, 2018·Human Vaccines & Immunotherapeutics·Zhichao ZhengMingtao Zeng
Apr 28, 2018·The Journal of Infectious Diseases·Jessica C JoycePaul A Rota
Jul 19, 2017·Pharmaceutical Research·M LeoneG Kersten
Apr 23, 2020·Advances in Wound Care·Muhammad BilalHafiz M N Iqbal
Jul 16, 2020·Human Vaccines & Immunotherapeutics·Thuy Trang NguyenJung-Hwan Park
Aug 5, 2017·Materials·Brendan KochHyo-Jick Choi
Jun 30, 2019·Advanced Materials·C Wyatt ShieldsSamir Mitragotri
Aug 3, 2020·Drug Delivery and Translational Research·Vahid AlimardaniMohammad Ashfaq
Jun 30, 2019·Bioengineering & Translational Medicine·Michelle E TurveyPaula T Hammond
Dec 8, 2017·ILAR Journal·Lisa A MillerEdward S Schelegle
Apr 27, 2017·Transactions of the Royal Society of Tropical Medicine and Hygiene·D N Durrheim, J L Goodson
Nov 30, 2019·Frontiers in Bioengineering and Biotechnology·Mario BattistiPaolo Antonio Netti
May 7, 2020·The Pan African Medical Journal·Lauren Christine Richardson, William John Moss
Sep 15, 2020·Expert Opinion on Drug Delivery·Emrullah KorkmazLouis D Falo
Oct 24, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Parbeen SinghXu Zhang
Jan 24, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Xiao Peng ZhangXin Dong Guo
Feb 1, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ilin SadeghiRobert Langer
Feb 5, 2021·Advanced Drug Delivery Reviews·Emrullah KorkmazLouis D Falo
Feb 19, 2021·Drug Delivery and Translational Research·Carmine D'AmicoHélder A Santos
Dec 20, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hamed AmaniHélder A Santos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Yeu-Chun KimMark R Prausnitz
© 2021 Meta ULC. All rights reserved